...
首页> 外文期刊>Molecular medicine reports >Overexpression of p16(ink4a) regulates the Wnt/beta-catenin signaling pathway in pancreatic cancer cells
【24h】

Overexpression of p16(ink4a) regulates the Wnt/beta-catenin signaling pathway in pancreatic cancer cells

机译:P16(INK4A)的过表达调节胰腺癌细胞中的WNT /β-连环蛋白信号传导途径

获取原文
获取原文并翻译 | 示例
           

摘要

The pathogenesis and etiology of pancreatic cancer remain to be fully elucidated; therefore, associated investigations are required to improve the outcome and prognosis of patients. In the present study, the effects of the overexpression of p16(ink4a) on the Wnt/beta-catenin signaling pathway were investigated in pancreatic cancer cell lines. Two pancreatic cancer cell lines, Bxpc-3 and Miapaca-2, characterized by low expression of p16(ink4a), were transfected with the pc-DNA3.0-p(16ink4a) plasmid. After 24 h, Reverse transcription-polymerase chain reaction and western blot analyses were performed to evaluate the expression of p16(ink4a), beta-catenin, which is a key molecule in the Wnt/beta-catenin signaling pathway, c-myc and cyclin D1, which are molecules downstream of beta-catenin. The expression of p16(ink4a) was significantly upregulated in the transfected cells. Consequently, the expression of beta-catenin was inhibited, whereas the expression levels of c-myc and cyclin D1 were not altered significantly. The increased expression of p16(ink4a) may affect the activity of Wnt/beta-catenin signaling through modulation of the expression of beta-catenin. The results of the present study provide information for the future development of targeted treatments for pancreatic cancer.
机译:胰腺癌的发病机制和病因仍然是完全阐明的;因此,需要相关的调查来改善患者的结果和预后。在本研究中,在胰腺癌细胞系中研究了P16(INK4A)过表达对WNT /β-连环蛋白信号传导途径的影响。用PC-DNA3.0-P(16Aink4a)质粒转染P16(INK4A)表征的两种胰腺癌细胞系,BXPC-3和MIAPACA-2。在24小时后,进行逆转录 - 聚合酶链反应和蛋白质印迹分析以评估P16(Ink4a),β-连环蛋白的表达,其是Wnt /β-连环蛋白信号传导途径,C-myc和Cyclin中的关键分子D1,其是β-catenin下游的分子。 P16(Ink4a)的表达在转染细胞中显着上调。因此,抑制了β-连环蛋白的表达,而C-MYC和细胞周期蛋白D1的表达水平没有显着改变。 P16(Ink4a)的表达增加可能通过调节β-catenin的表达来影响Wnt /β-catenin信号传导的活性。本研究结果为胰腺癌有针对性治疗的未来发展提供了信息。

著录项

  • 来源
    《Molecular medicine reports》 |2018年第1期|共5页
  • 作者单位

    Lanzhou Univ Hosp 1 Dept Gen Surg 2 Key Lab Biotherapy &

    Regenerat Med 1 Donggang West Rd;

    Lanzhou Univ Hosp 1 Dept Gen Surg 2 Key Lab Biotherapy &

    Regenerat Med 1 Donggang West Rd;

    Lanzhou Univ Hosp 1 Dept Gen Surg 2 Key Lab Biotherapy &

    Regenerat Med 1 Donggang West Rd;

    Lanzhou Univ Hosp 1 Dept Gen Surg 2 Key Lab Biotherapy &

    Regenerat Med 1 Donggang West Rd;

    Lanzhou Univ Hosp 1 Dept Gen Surg 2 Key Lab Biotherapy &

    Regenerat Med 1 Donggang West Rd;

    Lanzhou Univ Hosp 1 Dept Gen Surg 2 Key Lab Biotherapy &

    Regenerat Med 1 Donggang West Rd;

    Lanzhou Univ Hosp 1 Dept Gen Surg 2 Key Lab Biotherapy &

    Regenerat Med 1 Donggang West Rd;

    Lanzhou Univ Hosp 1 Dept Gen Surg 2 Key Lab Biotherapy &

    Regenerat Med 1 Donggang West Rd;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 基础医学;
  • 关键词

    p16(ink4a); Wnt; signaling pathway; pancreatic cancer;

    机译:P16(Ink4a);wnt;信号通路;胰腺癌;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号